BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 14610273)

  • 1. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.
    Zambrowicz BP; Abuin A; Ramirez-Solis R; Richter LJ; Piggott J; BeltrandelRio H; Buxton EC; Edwards J; Finch RA; Friddle CJ; Gupta A; Hansen G; Hu Y; Huang W; Jaing C; Key BW; Kipp P; Kohlhauff B; Ma ZQ; Markesich D; Payne R; Potter DG; Qian N; Shaw J; Schrick J; Shi ZZ; Sparks MJ; Van Sligtenhorst I; Vogel P; Walke W; Xu N; Zhu Q; Person C; Sands AT
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14109-14. PubMed ID: 14610273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
    Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
    Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
    Liu Z; Xie J; Wu T; Truong T; Auchus RJ; Huang CL
    Hum Mol Genet; 2011 Mar; 20(5):855-66. PubMed ID: 21131289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.
    Liu Z; Wang HR; Huang CL
    J Biol Chem; 2009 May; 284(18):12198-206. PubMed ID: 19244242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of WNK1 knockout cell lines by CRISPR/Cas-mediated genome editing.
    Roy A; Goodman JH; Begum G; Donnelly BF; Pittman G; Weinman EJ; Sun D; Subramanya AR
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F366-76. PubMed ID: 25477473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.
    Shekarabi M; Girard N; Rivière JB; Dion P; Houle M; Toulouse A; Lafrenière RG; Vercauteren F; Hince P; Laganiere J; Rochefort D; Faivre L; Samuels M; Rouleau GA
    J Clin Invest; 2008 Jul; 118(7):2496-505. PubMed ID: 18521183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
    O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
    J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.
    O'Reilly M; Marshall E; Speirs HJ; Brown RW
    J Am Soc Nephrol; 2003 Oct; 14(10):2447-56. PubMed ID: 14514722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.
    Delaloy C; Lu J; Houot AM; Disse-Nicodeme S; Gasc JM; Corvol P; Jeunemaitre X
    Mol Cell Biol; 2003 Dec; 23(24):9208-21. PubMed ID: 14645531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade.
    Xie J; Yoon J; Yang SS; Lin SH; Huang CL
    J Biol Chem; 2013 Mar; 288(12):8566-8574. PubMed ID: 23386621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.
    Xu B; English JM; Wilsbacher JL; Stippec S; Goldsmith EJ; Cobb MH
    J Biol Chem; 2000 Jun; 275(22):16795-801. PubMed ID: 10828064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
    Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variation in with no-lysine kinase 1 (WNK1) and blood pressure responses to dietary sodium or potassium interventions- family-based association study.
    Liu F; Zheng S; Mu J; Chu C; Wang L; Wang Y; Xiao H; Wang D; Cao Y; Ren K; Liu E; Yuan Z
    Circ J; 2013; 77(1):169-74. PubMed ID: 23059770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.
    Lazrak A; Liu Z; Huang CL
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1615-20. PubMed ID: 16428287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion.
    Newhouse S; Farrall M; Wallace C; Hoti M; Burke B; Howard P; Onipinla A; Lee K; Shaw-Hawkins S; Dobson R; Brown M; Samani NJ; Dominiczak AF; Connell JM; Lathrop GM; Kooner J; Chambers J; Elliott P; Clarke R; Collins R; Laan M; Org E; Juhanson P; Veldre G; Viigimaa M; Eyheramendy S; Cappuccio FP; Ji C; Iacone R; Strazzullo P; Kumari M; Marmot M; Brunner E; Caulfield M; Munroe PB
    PLoS One; 2009; 4(4):e5003. PubMed ID: 19347040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
    Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
    Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.